hemophilia
Showing 1 - 25 of 949
Lower Extremity Muscles in Patients With Hemophilia
Not yet recruiting
- Hemophilia
- +2 more
-
Gaziantep, Şahinbey, TurkeyHasan Kalyoncu University
Jul 31, 2023
Liver Biopsy Following Gene Therapy For Hemophilia
Not yet recruiting
- Hemophilia A
- Hemophilia B
- Liver Biopsy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 27, 2023
Patterns of Hemophilia Care in Assiut Children Patients
Not yet recruiting
- Hemophilia A
- Hemophilia B
- (no location specified)
Jul 29, 2023
Characterize Effectiveness and Safety of HEMGENIX® in Hemophilia
Not yet recruiting
- Hemophilia B
- HEMGENIX
- Factor IX (FIX)
- (no location specified)
Aug 23, 2023
Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)
Not yet recruiting
- Hemophilia B Without Inhibitor
- Low dose KL001
- +2 more
- (no location specified)
Nov 5, 2023
Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)
Not yet recruiting
- Hemophilia B Without Inhibitor
- Low dose KL001
- +2 more
- (no location specified)
Nov 5, 2023
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments
Completed
- Hemophilia A
- +2 more
- Vitamin K Antagonist - Drug
-
Brest, France
- +5 more
Apr 6, 2023
Hemophilia A, Hemophilia B Trial in Istanbul (Closed Chain Exercise Group, Proprioceptive Exercise Group)
Not yet recruiting
- Hemophilia A
- Hemophilia B
- Closed Chain Exercise Group
- Proprioceptive Exercise Group
-
Istanbul, Turkeyİstanbul University-Cerrahpaşa
May 18, 2023
Male Hemophilia B Previously Treated With Etranacogene
Not yet recruiting
- Hemophilia B
- AAV5-hFIXco-Padua
- (no location specified)
Jul 31, 2023
Hemophilia B With Inhibitor, Hemophilia B Trial (SerpinPC)
Not yet recruiting
- Hemophilia B With Inhibitor
- Hemophilia B
- (no location specified)
Mar 16, 2023
Bleeding Rates Among Severe Hemophilia A on Emicizumab
Not yet recruiting
- Hemophilia A
-
Newark, New JerseyNewark Beth Israel Medical Center
Oct 26, 2023
Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))
Not yet recruiting
- Hemophilia B
- CSL222 (AAV5-hFIXco-Padua)
- (no location specified)
Aug 14, 2023
Efanesoctocog Alfa on Long-term Joint Health in Hemophilia A
Not yet recruiting
- Hemophilia A
- Efanesoctocog Alfa BIVV001
- (no location specified)
Jun 19, 2023
Patients With End Stage Liver Disease
Not yet recruiting
- Liver Cirrhosis
- +6 more
-
Palo Alto, CaliforniaStanford Hospital
Aug 23, 2023
A Prospective and Retrospective Interventional Study on
Recruiting
- Severe Hemophilia A Without Inhibitor
- serum biomarker.
-
Taipei, Neihu Dist., TaiwanTri-Service General Hospital Hemophilia Care Center
Aug 10, 2023
Severe Hemophilia A Without Inhibitor, Joint Bleed Trial in Bangkok ("Emicizumab", "HEMLIBRA®")
Recruiting
- Severe Hemophilia A Without Inhibitor
- Joint Bleed
- "Emicizumab", "HEMLIBRA®"
-
Bangkok, ThailandKing Chulalongkorn Memorial hospital
Nov 25, 2023
Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)
Not yet recruiting
- Hemophilia A With Inhibitor
- SCT800 and Daratumumab
- (no location specified)
May 24, 2023
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Completed
- Hemophilia
- +7 more
-
Phoenix, Arizona
- +26 more
Jan 30, 2023
Hemophilia A Trial in Little Rock (ASC618)
Recruiting
- Hemophilia A
- ASC618
-
Little Rock, ArkansasArkansas Children's Hospital
Jan 30, 2023
Dynamics of Anti-factor VIII Antibody Signature During Treatment
Not yet recruiting
- Severe Hemophilia A
- +2 more
- no interventions
- (no location specified)
Apr 4, 2023
Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)
Recruiting
- Hemophilia A
- Single dose intravenous injection of BBM-H803
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital Chinese Academ
Oct 31, 2023
Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)
Recruiting
- Hemophilia B
- Sodium valproate extended-release tablets
-
Beijing, ChinaPLA General Hospital
Jun 17, 2023